Live Breaking News & Updates on Infrapopliteal Artery Disease

Stay updated with breaking news from Infrapopliteal artery disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

1. In this randomized controlled trial, for patients with chronic limb-threatening ischemia (CLTI) due to infrapopliteal artery disease (IAD), a drug-eluting resorbable scaffold was superior to angioplasty in reducing the risk of vascular events. 2. There was no significant difference in the adverse events between the drug-eluting resorbable scaffold and angioplasty groups. Evidence Rating Level: ....

Minute Medicine Inc , Rating Level , Confidence Interval , Chronic Disease , Drug Eluting Scaffold , Infrapopliteal Artery Disease , Limb Threatening Ischemia , Vascular Surgery ,

Everolimus-eluting scaffold found better than angioplasty for CLTI patients with infrapopliteal artery disease

Everolimus-eluting scaffold found better than angioplasty for CLTI patients with infrapopliteal artery disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Ramonl Varcoe , University Of New South Wales , Sciencex Network , Wales Hospital , New South Wales , Eluting Resorbable Scaffold , Infrapopliteal Artery Disease , New England Journal , Drug Eluting Resorbable Scaffold ,